基本信息
浏览量:0
职业迁徙
个人简介
Dr. Akram Al-Makki is a nephrologist practicing at Indiana University Health – Arnett in Lafayette, Indiana, USA. He received his medical degree from Damascus University Faculty of Medicine in 1992. He is board certified by the American Board of Internal Medicine in the specialty of Internal Medicine and the subspecialty of Nephrology. He is also affiliated with Indiana University School of Medicine and Purdue University College of Pharmacy. He has passion for medical research and medical education. He has been the Director of Graduate Medical Education at IU Health Arnett since 2012. He received multiple awards and recognitions for his involvement in teaching and patient care like the Trustee Teaching Award from Indiana University School of Medicine (IUSM), Outstanding Preceptor Award, The Indiana University Health West Central Region’s (WCR) Values Leadership Award (VLA) and The AC Arnett Award. He lectured nationally and internationally on topics related to chronic kidney disease as well as other areas in clinical nephrology and hypertension. He was a member of a team of nephrologists who developed a simplified approach to emergency dialysis using novel treatment approach via stand-alone blood pump powered by car battery for treatment of acute renal failure in field hospitals in Syria. This modality helped save many patients with acute renal failure whether caused by shock due to hemorrhage or by crush injury. In 2020, he was invited by the World Health Organization's (WHO) Department of Noncommunicable Diseases to become a Member of Guideline Development Group for the pharmacological treatment of hypertension in adults. He authored and coauthored multiple peer reviewed papers published in different esteemed journals and presented in national and international medical meetings.
Clinical Research Experience
• Principal Investigator in a study with Purdue University's College of Pharmacy: Ergocalciferol versus cholecalciferol in non-dialysis dependent chronic kidney disease patients: a retrospective cohort study
• Principal Investigator of the CentrosFLO Trial
• Member of Clinical Research Oversight Committee at Indiana University Health Arnett
• Principal Investigator in: Principal Investigator in: AZEPTIC Trial for Zuragen™
• Principal Investigator in: Affymax (AFX01-11) Trial (PEARL Study)
• Sub-Investigator in AMGEN’s Cinacalcet in CKD study
• PhD research committee member and advisor for PhD student from 2003 – 2008 at Rocky Mountain University of Health Professions
研究兴趣
论文共 25 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of the American Society of Nephrologyno. 11S (2023): 731-732
Sami Alasfar, Wasim Zakaria, Khaled Haj Nasan,Abdul R Zanabli,Fahd Al-Saghir,Ahmad Oussama Rifai, Valerie Luyckx,Lina Murad,Saleh Kaysi,Akram Al-Makki,Mohamed Sekkarie
Kidney internationalno. 2 (2023): 221-224
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2023): 11892-11892
SEMINARS IN NEPHROLOGYno. 4 (2020): 354-362
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn